Radioactive injection targets Tough-to-Treat cancers in new trial
Disease control
Recruiting now
This early-stage study is testing a new radioactive drug injection called 177Lu-CTR-FAPI in patients with advanced, metastatic cancers like pancreatic cancer. The main goals are to see if the treatment is safe, to measure how much radiation reaches the tumors, and to check if it …
Phase: EARLY_PHASE1 • Sponsor: Yan Xing • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC